Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
1.44M
-
Shares change
-
+355K
-
Total reported value, excl. options
-
$3.02M
-
Value change
-
+$637K
-
Number of buys
-
11
-
Number of sells
-
-9
-
Price
-
$2.10
Significant Holders of Lexaria Bioscience Corp. - COM NEW (LEXX) as of Q4 2024
31 filings reported holding LEXX - Lexaria Bioscience Corp. - COM NEW as of Q4 2024.
Lexaria Bioscience Corp. - COM NEW (LEXX) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.44M shares
.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (460K shares), Invenomic Capital Management LP (411K shares), GEODE CAPITAL MANAGEMENT, LLC (167K shares), VANGUARD GROUP INC (127K shares), RAYMOND JAMES FINANCIAL INC (60.6K shares), STATE STREET CORP (39.3K shares), WEALTH ENHANCEMENT ADVISORY SERVICES, LLC (28.9K shares), BlackRock, Inc. (27.4K shares), HighTower Advisors, LLC (21K shares), and MORGAN STANLEY (20.2K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.